The International Congress Late-Breaking Abstract Submission is Now Open
To submit a Late-Breaking Abstract for the 2019 International Congress in Nice, France, please click the button below. The deadline for 2019 abstract submissions is May 24, 2019 11:59 pm (CDT). Late submissions will not be accepted. Late-Breaking Abstracts notification e-mails will be sent in July.
Late-Breaking Abstracts will be considered for presentation and publication at the 2019 International Congress if they fulfill the following criteria:
1. The topic must be of critical importance to the clinical/scientific community and/or the public.
2. The abstract must be report data that became available for public dissemination only after the deadline of the regular abstract submission (March 1, 2019), and has not been previously published or presented.
3. The study and results reported should be novel (not simply an extension of previously published work) or be definitive of confirming or refuting other critically important work.
4. The following categories are typically suited to the main poster sessions and will not be considered for Late-Breaking Abstracts: case reports, qualitative surveys, reviews of existing treatments, practice reviews, rating scale validation, small confirmatory studies, small scale epidemiology studies, research proposals.
5. The Late-Breaking Abstract program is not designed to favor investigators who inadvertently missed the deadline for regular abstract submission.
The International Parkinson and Movement Disorder Society invites all MDS Members and non-members to submit an abstract for review for the 2019 International Congress. Please note the following criteria:
- There is no fee to submit an abstract
- All abstract submissions must be original research
- All abstracts must be submitted and presented in English
- Abstracts that have been presented at other meetings may be submitted if they have not been published and if the meeting name and date are cited accordingly
- If your abstract is accepted, you must be prepared to travel to the 2019 International Congress to present your abstract as a printed poster on the assigned date
MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or of a group. Should plagiarism be detected, the abstract will be rejected.
Abstract Submission Format
Please read the following section before submitting your abstract for review. To view examples of MDS abstracts, please visit the MDS Abstracts webpage. The sole means of abstract submission is through the online submission system.
Please limit the abstract title and body text to 2,500 characters (including spaces). Please refrain from using special characters within the abstract text.
Abstracts should adhere to the following format:
- Objective (250 character maximum)
- Background (250 character maximum)
- Methods (750 character maximum)
- Results (750 character maximum)
- Conclusions (750 character maximum)
You will be asked to list the name, affiliation and e-mail for each co-author, however, all communications and notifications regarding abstract submissions will be sent only to the submitting author.
The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands. Non-proprietary (generic) drug names should be used and should be written without capital letters in all instances.
If you are including tables or figures within your abstract, you must enter the appropriate ID tag in the abstract body where you would like your tables and/or figures to appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure. You may upload the tables within the abstract submission website.
Terms & Conditions
MDS expects that all abstracts selected for presentation will be presented as a printed poster and that no submitted abstracts will be withdrawn. Please do not submit an abstract if you are not prepared to travel to the 2019 International Congress and present your abstract as scheduled by MDS.
Abstract presenters should plan to attend the 2019 International Congress September 22-26, 2019, as poster presentation dates are subject to change.
MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or of the group. Should plagiarism be detected, the abstract will be rejected.
All submitted abstracts become the property of MDS.